info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Remote Patient Monitoring Market Size

ID: MRFR//9421-HCR | 120 Pages | Author: Rahul Gotadki| November 2024

The Remote Patient Monitoring Market is forecast to get up to USD 7.27 Billion by 2030 at 18.64% CARGF during the forecast period (2022-2030). The Remote Patient Monitoring (RPM) Market is influenced by multiple factors which shape as whole and results in its dynamics. One of the critical factors is the mounting need for people-centered, cost-effective and quality-driven health solutions, with the inevitably growing number of aged people and the disease burden. Remote Patient Monitoring via technology provides a means by which the provider can monitor the patient's vital signs and health information from a distance to help reduce the frequency of hospital visits and hence improve healthcare outcome.

Technological breakthroughs act as key factors for the Remote Patient Monitoring market development. Continuously improving of wearable devices, sensors, and wireless technologies has increased the capacity of RPM systems (remote patient monitoring systems). Among several other things, these techologies facilitate for the real-time monitoring of patients' various health parameters like heart rate, blood pressure, etc. The implementation of digital platforms which promote online discussions between healthcare professionals and patients promotes proactive and personalized approach to patients' care.

The distribution of Government policies and reimbursement procedure significantly drive the growth of the Remote patient monitoring market. Taking into consideration the advantages which remote monitoring brings in enhancing patient outcomes as well as lowering healthcare expenditures, the government has initiated policies to stimulate the rollout of these RPM solutions. The reimbursement models that encourage remote patient monitoring service provisioning act as a financial backup for healthcare providers who use those technologies as part of their care delivery models.

Chronic diseases incidence including diabetes, cardiovascular and respiratory diseases are the factors contributing this demand for Remote Patient Monitoring solutions. Constant observation of patients with chronic illnesses presents a possibility to detect complications and give timely treatment in due course, as well as to improve therapy schedules. This, however, not only helps in improving patients outcomes, but also, manages health systems strain.

The economy aspect, such as the costs of healthcare delivery and the medium for healthcare cost savings, carries out the implementation of Remote Patient Monitoring systems. RPM is an important strategy that improving the hospital readmission rate, averting complications, and facilitating precautionary care and thus increasing the efficiency of healthcare delivery system. Market vendors have to convince healthcare providers about the economic benefits and return on investment associated with their remote health monitoring solutions to incentivize their widespread use across healthcare settings.

Covered Aspects:

Report Attribute/Metric Details
Market Size Value In 2022 USD 2.2 Billion
Market Size Value In 2023 USD 2.61 Billion
Growth Rate 18.64% (2022-2030)

Global Remote Patient Monitoring Market Overview


Remote Patient Monitoring Market Size was valued at USD 18.23 Billion in 2023. The Global Remote Patient Monitoring industry is projected to grow from USD 21.67 Billion in 2024 to USD 88.92 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 19.30% during the forecast period (2024 - 2032). 


The increasing geriatric population and growing investments in telemedicine are the key market drivers enhancing market growth.


Remote Patient Monitoring Market Overview 12


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


July 2024: Philips expanded its remote patient monitoring solutions with the new Philips Care Orchestrator, which integrates advanced analytics to enhance patient outcomes and streamline care for chronic conditions.


June 2024: Medtronic launched the Minimed 780G insulin pump system with advanced remote monitoring, offering real-time glucose data sharing with healthcare providers to improve diabetes management and reduce hospital visits.


Remote Patient Monitoring Market Trends



  • Rising  Geriatric Population to Fuels Market Growth


According to the World Health Organization the worldwide population over 60 is expected to grow from 12% in 2015 to 22% in 2050, increasing the risk of developing chronic diseases and complications. An increase in chronic diseases such as osteoarthritis, chronic obstructive pulmonary disease, diabetes, depression, heart disease and dementia are prevalent in this population. Therefore, various solutions for remote monitoring patients to treat these diseases are being increasingly used, which drives the market CAGR.


Furthermore, there is a growing need for continuous monitoring of vital signs and effective treatment of disease. For instance, according to a study published in the American Medical Informatics Association (JAMIA) Journal, remote patient monitoring boosts patient engagement in managing chronic diseases.


Figure 1 Percentage of the worlds population over 65 years from 1950-2050 (% of population)Percentage of the worlds population over 65 years from 1950-2050


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Technological advances and the cost advantages of remote patient monitoring have driven the adoption of remote patient monitoring technology for many years. People tend to monitor their health daily with home monitors. Patients can easily assess temperature, respiratory rate, heart rate, blood pressure and more via wearable devices in point-of-care settings without disrupting their daily lives. Devices are getting cheaper and cheaper as adoption increases. Thus, driving the  Remote Patient Monitoring market revenue.


Integration of AI and machine learning algorithms into RPM systems has allowed for more advanced predictive analytics. These systems can analyze vast amounts of patient data to predict potential health issues before they become critical, enabling proactive care.


For instance, Philips and Biofourmis are leading in AI-driven platforms providing real-time insights and early warnings for conditions like heart failure and COPD.


Remote Patient Monitoring Market Segment Insights


Remote Patient Monitoring Type Insights


The market segmentation of remote patient monitoring is based on Type includes devices, and services. The services Remote Patient Monitoring segment held the majority share in 2022 with respect to the market revenue of remote patient monitoring. Rising demand for remote patient monitoring services during the COVID-19 pandemic fueled revenue growth. In addition, major players' technological advancements and new product launches contribute to the growth of remote patient monitoring services for, cardiac monitoring, vital signs and blood glucose monitoring in the  market. For instance, in October 2021, OnSkyHealth International launched SkyPad, a virtual care solution designed to provide contactless monitoring of patient vital signs.


Remote Patient Monitoring Application Insights


Applications have bifurcated the  Remote Patient Monitoring market data into Cancer, Cardiovascular Diseases, and Diabetes. The Cardiovascular Diseases segment dominated the market in 2022, and the Diabetes segment is anticipated to be the fastest-growing segment during the period, 2024-2032. The increasing occurrence of chronic diseases and rising patient visits are the major reason for the growth of this segment in the market.


Remote Patient Monitoring End-User Insights


The market Components of Remote Patient Monitoring, based on End-User, include Hospitals, Clinics, and Others. The hospitals segment led the market in 2022 and is anticipated to be the fastest-developing segment during the period, 2024-2032, due to the growing number of prehospital patient visits. In addition, the pandemic has further improved the adoption rate due to the social-distancing norms enforced by countries.


The patient segment is anticipated to experience fastest progress during the forecast period owing to the increasing awareness among the patient population regarding the need for real-time monitoring of health parameters. The implementation of affordable health plans by payers will help patients adopt devices that embrace digital transformation. Thus, supporting patients in implementing affordable devices is projected to leverage the growth of the patient segment. Hence, rising End-User options for Remote Patient Monitoring positively impact the market growth


Figure 2  Remote Patient Monitoring Market Share By End-User 2024-2032 (USD Billion)Remote Patient Monitoring Market Share By End-User


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Remote Patient Monitoring Regional Insights


By region, the study offers market insights into Asia-Pacific, Europe, North America,  and Rest of the World. The North America remote patient monitoring market accounted for USD 1.00 billion in 2022 and is projected to display a significant CAGR growth during the study period attributed to the greater adoption of monitoring devices by patients and hospital settings. Moreover, Increasing investment in the introduction of sophisticated devices for enhanced quality care of the patient pool is accountable for the region dominant market share in 2022. 


North American market players constantly focus on product development and partnership strategies to expand their business offerings in North America. Further, the United States market of remote patient monitoring held the largest market share, and the Canada market of remote patient monitoring was the fastest-growing market in the North American region.


Further, the key countries studied in the market report are The U.S, Canada, UK, Italy, Spain, Germany, France, China, Japan, India, Australia, South Korea, and Brazil.


Figure 3  REMOTE PATIENT MONITORING MARKET SHARE BY REGION 2022 (%)REMOTE PATIENT MONITORING MARKET SHARE BY REGION


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe's remote patient monitoring market accounts for the second-largest market share due to the rapid adoption of the devices, favorable regulatory scenario, and availability of adequate healthcare infrastructure. In addition, strategic partnerships among the companies to offer whole remote patient monitoring to patients are contributing to the introduction of these monitoring devices in the region leading to higher adoption. Moreover, the UK market of remote patient monitoring held the largest market sharenwhereas Germany market of remote patient monitoring is the fast growing in the region.


The Asia-Pacific Remote Patient Monitoring Market is anticipated to grow at the fastest CAGR from 2024-2032. Rising patient responsiveness regarding blood glucose monitoring devices coupled with cardiac monitors leads to higher adoption of these devices in the region. In addition, the penetration of companies in rural areas and improving healthcare systems in countries such as India, Australia, and Southeast Asia are expected to drive the market. 


Key players are devising market entry strategies to expand their business presence in the Asia Pacific. Moreover, the China market of remote patient monitoring held the largest market sharenwhereas India market of remote patient monitoring is the fast growing in the Asia-Pacific region.


Remote Patient Monitoring Key Market Players & Competitive Insights


Key market players are spending a huge amount of money on research & development to increase their product lines, which will aid the market growth of remote patient monitoring. Market players are also taking numerous strategies to grow their  footprint, with vital market developments such as increased investments, contractual agreements, mergers, new product launches, and acquisitions, and collaboration with other organizations. Competitors in the remote patient monitoring industry must expand their business footprint to stay alive in an progressively competitive and mounting market atmosphere.


One of the major business strategies industries adopt in the  remote patient monitoring manufacturing to help clients and increase the market sector by increasing investment in R&D to improve solutions and services. In recent years, the remote patient monitoring industry has provided reduced disruptions and transparency in the supply chain. 


The remote patient monitoring market key player such as Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers AG (Germany), OMRON Healthcare (Japan), Boston Scientific Corporation (US), Abbott Laboratories (US), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), Philips (US) and others are working on increasing the market demand by investing in research and development activities.


Philips is an American-based company that helps people to prevent disease and live healthily. Giving clinicians tools need to make a precision diagnosis and bring personalized treatment. For instance, In November 2019, Philips announced the launch of EarlyVue VS30, vital signs monitor in the U.S. The monitor aims to collect critical vital signs data and allow clinicians to appropriately identify the patient's health.


Medtronic plc is an American medical device company. It primarily operates in the United States, operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. For instance, in July 2020, Medtronic announced the clearance of Linq II insertable cardiac monitor (ICM) by the European CE mark and U.S. food and drug administration. The monitor is equipped with remote programming that allows clinicians to monitor patients and change device settings without the physical need of patients in hospitals and clinics.


Key Companies in the Remote Patient Monitoring market include



  • Koninklijke Philips N.V. (Netherlands)

  • Medtronic plc (Ireland)

  • GE Healthcare (US)

  • Cerner Corporation (US)

  • Siemens Healthineers AG (Germany)

  • OMRON Healthcare (Japan)

  • Boston Scientific Corporation (US)

  • Abbott Laboratories (US)

  • Nihon Kohden Corporation (Japan)

  • OSI Systems, Inc. (US)

  • Philips


Remote Patient Monitoring Industry Developments


June 2024: Philips has upgraded its remote patient monitoring platform with AI-powered predictive analytics, enabling early intervention in chronic conditions patients.


April 2024: Medtronic has introduced an AI-driven insulin monitoring solution for diabetes management, offering real-time glucose monitoring and predictive insights. The system automatically adjusts insulin delivery based on continuous glucose monitor readings, promoting a more personalized approach to diabetes care and improving glycemic control.


March 2024: Abbott Laboratories has introduced next-generation wearable biosensors, which monitor multiple biomarkers simultaneously, providing real-time data for remote monitoring by healthcare providers, especially for patients with chronic conditions, using a cloud-based platform.


Remote Patient Monitoring Market Segmentation


Remote Patient Monitoring Type Outlook



  • Devices

  • Services


Remote Patient Monitoring Application Outlook



  • Cancer

  • Cardiovascular Diseases

  • Diabetes


Remote Patient Monitoring End-User Outlook



  • Payers

  • Providers

  • Patients


Remote Patient Monitoring Regional Outlook



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.